What Is Stronger Than Naproxen 500 mg?

Several medications outperform naproxen 500 mg for pain relief, but which one depends heavily on the type of pain you’re dealing with. For inflammatory joint pain, prescription NSAIDs like diclofenac at full dose and etoricoxib rank higher in head-to-head analyses. For nerve pain, naproxen barely registers, and drugs like gabapentin leave it behind entirely. Perhaps most surprising, common opioid combinations that people assume are “stronger” often perform no better than naproxen and come with far worse side effects.

Why Simply Taking More Naproxen Does Not Work

Before looking at alternatives, it helps to understand why you can’t just increase the naproxen dose to get more relief. NSAIDs as a class have what researchers call a ceiling effect: beyond a certain dose, you get more side effects but no additional pain relief. A meta-analysis of NSAIDs for cancer pain found that recommended and supramaximal single doses of several NSAIDs produced comparable changes in pain scores, confirming that pushing the dose higher does not push pain lower.¹ For naproxen specifically, the standard prescription ceiling is 1,000 mg per day (two 500 mg tablets). Going above that doesn’t buy you meaningful extra relief but does increase the chance of stomach bleeding, kidney strain, and cardiovascular problems.

This ceiling is the core reason people end up asking the question in the first place. If naproxen 500 mg twice daily isn’t cutting it, the answer isn’t a higher dose of the same drug. It’s a different drug, a different mechanism, or a combination approach.

Prescription NSAIDs That Outperform Naproxen

Not all NSAIDs are created equal when it comes to raw pain-relieving power. A large network meta-analysis comparing traditional NSAIDs and COX-2 inhibitors in people with osteoarthritis or rheumatoid arthritis found that diclofenac at 150 mg per day was likely more effective at alleviating pain than naproxen at 1,000 mg per day, as well as ibuprofen and celecoxib at their standard doses.² At the lower 100 mg per day dose, diclofenac was roughly comparable to the others, so the advantage requires full-strength prescribing.

Etoricoxib, a COX-2 selective NSAID available in many countries outside the United States, consistently ranks at or near the top in efficacy analyses. A mixed treatment comparison for osteoarthritis found that even etoricoxib at just 30 mg had a greater-than-90-percent probability of producing at least small clinical improvements in pain over celecoxib, acetaminophen, and lumiracoxib.³ A separate Bayesian meta-analysis based on patient withdrawals found that people on etoricoxib were less likely to drop out of trials due to lack of efficacy compared with those on naproxen or celecoxib, though the difference didn’t reach statistical significance.⁴ Etoricoxib’s advantage is modest, but it’s real and consistent across analyses.

Ketorolac is another NSAID worth mentioning, though it’s typically reserved for short-term use. In a trial of acute low back pain, ketorolac was not inferior to naproxen over five days, but it did provide faster initial relief: about a quarter of ketorolac patients reported improved pain within 60 minutes of the first dose, compared with roughly 7 percent of naproxen patients.⁵ Ketorolac hits harder and faster in the short term but carries serious gastrointestinal risks that limit it to about five days of oral use.

Opioids Often Are Not Actually Stronger

This is where popular assumptions get turned upside down. Many people think that if naproxen isn’t working, they need something “stronger” like an opioid. The research tells a different story for many common pain scenarios.

In a randomized, double-blind trial of pain after dental surgery, naproxen sodium was significantly more effective than a hydrocodone-plus-acetaminophen combination across almost every measure: total pain relief over 12 hours, time until rescue medication was needed, and duration of meaningful pain reduction. The opioid combination was not statistically superior to naproxen on any endpoint. Meanwhile, 63 adverse events were reported in the opioid group compared with just 2 in the naproxen group.⁶ That’s not a typo. The NSAID beat the opioid and caused a fraction of the side effects.

Tramadol, a weak opioid frequently prescribed when NSAIDs seem insufficient, fares no better. In a trial comparing tramadol and naproxen after cesarean delivery, there was no difference in pain scores at 6, 12, 24, or 48 hours. Women on tramadol requested additional breakthrough pain medication more often, experienced about twice as many adverse effects, and were more likely to abandon the study entirely.⁷ A separate trial comparing the two drugs during gynecological procedures found identical analgesic efficacy, but tramadol’s side effects were significantly more severe and interfered with patients’ ability to resume normal activities.⁸

There is one context where tramadol had an edge: during IUD insertion, tramadol produced significantly lower pain scores than naproxen.⁹ But the overall picture is clear. For most acute pain, tramadol and low-dose opioid combinations are not meaningfully “stronger” than naproxen 500 mg and cause considerably more nausea, vomiting, dizziness, and sedation. The idea that moving to an opioid represents moving up a potency ladder is more cultural belief than clinical fact for many types of pain.

Adding Acetaminophen to Naproxen

One of the simplest and best-supported strategies for getting more pain relief than naproxen alone is to take acetaminophen (paracetamol) alongside it. The two drugs work through different pathways, and research in animals has demonstrated synergistic interaction between acetaminophen and multiple NSAIDs, including naproxen, meaning the combination produces more relief than you’d expect by simply adding each drug’s effect together.¹⁰ Clinical studies across musculoskeletal conditions, dental pain, and post-surgical settings have confirmed that this combination provides additive pain relief while allowing lower doses of each drug.¹¹

The evidence isn’t entirely uniform, however. One randomized trial in emergency department patients with acute post-trauma pain found that combining a high-dose NSAID with acetaminophen did not improve analgesia compared with acetaminophen alone.¹² The majority of evidence supports a benefit from the combination, but if you’re already on the maximum dose of both and still hurting, a different approach is probably needed rather than expecting the combination to overcome severe pain on its own.

What About Adding a Muscle Relaxant?

For low back pain, which is one of the most common reasons people take naproxen, a logical next thought is adding a muscle relaxant. The evidence here is surprisingly mixed. An older trial found that combining naproxen with cyclobenzaprine (a commonly prescribed muscle relaxant) led to less objective muscle spasm and tenderness and greater range of motion in the lower back compared with naproxen alone.¹³

But a more rigorous randomized trial told a less encouraging story. Researchers gave all participants naproxen and then randomly added either cyclobenzaprine, an oxycodone/acetaminophen combination, or placebo. At one week, all three groups improved by nearly identical amounts on a standardized disability questionnaire. Neither the muscle relaxant nor the opioid combination added any meaningful benefit over naproxen with a placebo pill.¹⁴ A separate emergency department trial that tested two other muscle relaxants (orphenadrine and methocarbamol) alongside naproxen reached the same conclusion: no improvement in functional outcomes over naproxen plus placebo.¹⁵

The takeaway: for acute low back pain without a clear spasm component, stacking a muscle relaxant on top of naproxen is unlikely to help much. The earlier positive trial may have been capturing a benefit in a subgroup of patients with prominent muscle spasm. If spasm isn’t the main problem, you probably won’t notice a difference.

Corticosteroids for Certain Conditions

Corticosteroids like prednisolone work through a fundamentally different anti-inflammatory mechanism than NSAIDs, and for certain conditions, they can be more effective. In a double-blind equivalence trial for acute gout, oral prednisolone at 35 mg per day produced virtually the same pain reduction as naproxen 500 mg twice daily over four days.¹⁶ A meta-analysis of randomized trials confirmed that finding: oral prednisolone at 30 to 35 mg per day was comparable to NSAIDs for gout pain relief at every time point measured.¹⁷ This matters most for people who can’t tolerate NSAIDs, such as those with kidney disease or a history of stomach ulcers, since prednisolone offers an equally effective alternative for gout flares.

For dental and post-surgical pain, corticosteroids may actually have an edge. A systematic review of pain after root canal treatment found that corticosteroids given orally as a premedication produced better analgesic outcomes than NSAIDs at various time points.¹⁸ Corticosteroid injections, too, can outperform oral NSAIDs when targeted directly at the source of inflammation. In patients with frozen shoulder, corticosteroid injections produced faster pain relief and quicker recovery of shoulder function during the first eight weeks compared with oral NSAIDs alone.¹⁹

The limitation of corticosteroids is that they’re not designed for long-term daily use. Short courses work well for acute flares and post-procedural pain, but extended use introduces its own problems, including bone thinning, blood sugar changes, and immune suppression. They are a powerful tool for specific situations, not a permanent replacement for naproxen.

When the Pain Is Nerve-Based, NSAIDs Barely Register

If your pain has a burning, shooting, or tingling quality, or if it persists after spinal surgery, you may be dealing with neuropathic pain. This is the one context where naproxen is clearly outclassed, not because a “stronger” version of the same thing exists, but because the mechanism driving the pain is fundamentally different and largely unresponsive to NSAIDs.

A trial of patients with persistent pain after spinal surgery compared gabapentin (titrated up to 1,800 mg per day) with naproxen (up to 1,500 mg per day). At maximum dose, gabapentin reduced back pain by about 20 percent and leg pain by about 39 percent. Naproxen achieved only a 7.7 percent reduction in leg pain at its maximum dose, and whatever slight improvement it produced faded over time.²⁰ A Cochrane systematic review broadly concluded that oral NSAIDs lack good evidence of usefulness for neuropathic pain in adults.²¹

Interestingly, combining gabapentin or pregabalin with naproxen may produce synergistic effects for certain types of inflammatory nerve pain. Animal research has shown that when gabapentin and naproxen are given together in the right ratios, they interact synergistically to reverse thermal hyperalgesia, meaning the combination outperforms what you’d expect from adding each drug’s effect alone.²² This suggests that for mixed pain states where both inflammation and nerve sensitization are at play, using naproxen alongside a nerve pain medication could be more effective than switching to either one alone.

The Safety Tradeoff You Should Know About

Stronger pain relief almost always comes with a safety cost, and one of naproxen’s underappreciated advantages is its cardiovascular safety profile. A network meta-analysis of NSAID cardiovascular risks found that naproxen seemed least harmful among all the NSAIDs studied. Diclofenac and etoricoxib, the two drugs that tend to edge ahead on pain relief, were associated with the highest risks of cardiovascular death.²³ In a cohort study of patients who had already been hospitalized for serious coronary heart disease, naproxen users had the lowest rates of subsequent heart attacks and cardiovascular death among all NSAID users. Diclofenac and ibuprofen carried higher risk relative to naproxen.²⁴

On the gastrointestinal side, ketorolac stands out as the most dangerous. A meta-analysis found that ketorolac carried the highest risk of GI bleeding among all NSAIDs studied, with roughly 20 times the odds compared with non-users. Among non-selective NSAIDs, ibuprofen had the lowest significant risk. Celecoxib, the COX-2 selective option, had the lowest overall GI bleeding risk of any NSAID in the analysis.²⁵ An earlier study pegged ketorolac’s relative risk at nearly 25 times that of non-users, with piroxicam also notably elevated.²⁶

This creates an unavoidable tradeoff. Diclofenac and etoricoxib offer modestly better pain control than naproxen for arthritis, but both carry higher cardiovascular risk. Ketorolac hits fast and hard but is the most dangerous NSAID for your stomach. Celecoxib is gentle on the gut but slightly less effective for pain than naproxen at full dose. There is no NSAID that wins on every front simultaneously, and naproxen’s position as a go-to drug for chronic inflammatory pain exists precisely because it balances decent efficacy with the best cardiovascular track record in its class.

Why the Same Pill Works Differently in Different People

If you’ve ever felt like naproxen works well for a friend but barely touches your pain, genetics may be part of the explanation. Naproxen is broken down in the liver primarily by an enzyme called CYP2C9, and the gene that codes for this enzyme comes in several variants. A study measuring naproxen levels in saliva found that people carrying certain CYP2C9 variants showed significantly different drug distribution and elimination rates compared with people carrying the standard version of the gene.²⁷ These variants are not rare; they’re carried by a meaningful fraction of the population, with frequency varying by ethnic background.

What this means in practice is that two people can take the same 500 mg naproxen tablet and end up with meaningfully different drug concentrations in their blood. One person might be a fast metabolizer who clears the drug quickly and feels the effect wearing off well before the next dose, while another might be a slow metabolizer who gets a stronger, longer-lasting response. This variability doesn’t change which drugs are “stronger” on average across populations, but it does explain why the question “what’s stronger than naproxen?” sometimes has a personal answer: a different NSAID that your body happens to process more favorably. If naproxen consistently underperforms for you, it’s worth discussing alternative NSAIDs with a prescriber rather than assuming all drugs in the class will fail equally.

Matching the Drug to the Pain

The most practical way to think about what’s “stronger” than naproxen 500 mg is to stop thinking in terms of a linear strength ladder and start thinking about what kind of pain you’re treating. For osteoarthritis and rheumatoid arthritis, full-dose diclofenac or etoricoxib provides modestly better pain control, with cardiovascular tradeoffs. For acute gout, prednisolone is equally effective and avoids the stomach risks. For acute dental or surgical pain, naproxen already performs as well as or better than common opioid combinations. For nerve-based pain, gabapentin or pregabalin will outperform naproxen dramatically. And for many types of mild-to-moderate pain, simply adding acetaminophen to your naproxen gives you a genuine boost without changing your risk profile in any major way.

The question most people are really asking when they search for something “stronger” is whether their pain can be better controlled. Often the answer isn’t a more powerful version of the same type of drug. It’s a different type of drug aimed at the mechanism actually driving the pain, or a smarter combination of drugs they may already have in the medicine cabinet.